Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
2.660
+0.650 (32.34%)
Apr 3, 2025, 4:00 PM EST

Aptose Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5132053122390
Upgrade
Market Cap Growth
-33.27%-33.27%-62.12%-56.27%-68.80%-9.61%
Upgrade
Enterprise Value
8163-327252
Upgrade
Last Close Price
2.016.7676.20261.00607.501971.00
Upgrade
PB Ratio
-1.47-1.47-6.941.411.643.28
Upgrade
P/TBV Ratio
---1.411.643.28
Upgrade
Debt / Equity Ratio
-1.17-1.17-0.350.040.010.01
Upgrade
Quick Ratio
--0.613.829.6817.97
Upgrade
Current Ratio
--0.784.0310.0018.36
Upgrade
Return on Equity (ROE)
---293.95%-74.70%-67.67%-51.91%
Upgrade
Return on Assets (ROA)
---102.23%-39.87%-39.18%-30.75%
Upgrade
Return on Capital (ROIC)
---176.13%-46.77%-42.00%-32.36%
Upgrade
Earnings Yield
-509.28%-189.15%-254.17%-78.63%-53.73%-14.17%
Upgrade
FCF Yield
-720.61%--221.47%-60.81%-35.77%-8.71%
Upgrade
Buyback Yield / Dilution
-210.43%-210.43%-9.82%-3.57%-8.86%-63.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.